Document Preview Unavailable
Efficacy and Safety of Canagliflozin in Individuals Aged 75 and Older with Type 2 Diabetes Mellitus: A Pooled Analysis
You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library